ムービー
コントローラー
構造ビューア
EMN検索について
-検索条件
-検索結果
検索 (著者・登録者: daniel & gr)の結果1,036件中、1から50件目までを表示しています
EMDB-45005: 
Paired Helical Filament of tau amyloids found in Down Syndrome individuals
EMDB-45007:
Straight Filament of tau amyloids found in Down Syndrome individuals
EMDB-45008:
Paired Helical Filaments purified from Down Syndrome individual brain tissue applied to graphene oxide antibody affinity grids
EMDB-45009:
Straight Filaments purified from Down Syndrome individual brain tissue applied to graphene oxide antibody affinity grids
PDB-9bxi:
Paired Helical Filament of tau amyloids found in Down Syndrome individuals
PDB-9bxo:
Straight Filament of tau amyloids found in Down Syndrome individuals
PDB-9bxq:
Paired Helical Filaments purified from Down Syndrome individual brain tissue applied to graphene oxide antibody affinity grids
PDB-9bxr:
Straight Filaments purified from Down Syndrome individual brain tissue applied to graphene oxide antibody affinity grids
EMDB-50580:
SOLIST cryo-tomogram of native left ventricle mouse heart muscle #1
EMDB-50582:
SOLIST native mouse heart muscle tomogram #2
EMDB-19163:
Trimeric HSV-1F gB ectodomain in postfusion conformation with three bound HDIT101 Fab molecules.
EMDB-19164:
Trimeric HSV-1F gB ectodomain in postfusion conformation with three bound HDIT102 Fab molecules.
EMDB-19165:
Trimeric HSV-2F gB ectodomain in postfusion conformation with three bound HDIT101 Fab molecules.
EMDB-19166:
Trimeric HSV-2G gB ectodomain in postfusion conformation with three bound HDIT102 Fab molecules.
PDB-8rgz:
Trimeric HSV-1F gB ectodomain in postfusion conformation with three bound HDIT101 Fab molecules.
PDB-8rh0:
Trimeric HSV-1F gB ectodomain in postfusion conformation with three bound HDIT102 Fab molecules.
PDB-8rh1:
Trimeric HSV-2F gB ectodomain in postfusion conformation with three bound HDIT101 Fab molecules.
PDB-8rh2:
Trimeric HSV-2G gB ectodomain in postfusion conformation with three bound HDIT102 Fab molecules.
EMDB-16375:
SARS-CoV2 Omicron BA.1 RBD in complex with CAB-A17 antibody
PDB-8c0y:
SARS-CoV2 Omicron BA.1 RBD in complex with CAB-A17 antibody
EMDB-43712:
Human EBP complexed with compound 1
EMDB-43713:
Human EBP complexed with compound 3a
PDB-8w0r:
Human EBP complexed with compound 1
PDB-8w0s:
Human EBP complexed with compound 3a
EMDB-42074:
Representative tomogram of Enterococcus faecium WT Com15
EMDB-42086:
Representative tomogram of Enterococcus faecium SagA complementation strain
EMDB-42087:
Representative tomogram of Enterococcus faecium SagA deletion strain
EMDB-19014:
PDCoV spike glycoprotein ectodomain in complex with the 22C10 antibody Fab fragment
EMDB-19015:
Local refinement of the PDCoV spike glycoprotein ectodomain in complex with the 22C10 antibody Fab fragment
EMDB-19016:
S1B domain of the PDCoV spike glycoprotein in complex with the 67B12 and 42H3 antibody Fab fragments
EMDB-19017:
S1B domain of the PDCoV spike glycoprotein in complex with the 67B12 and 46E6 antibody Fab fragments
PDB-8r9w:
PDCoV spike glycoprotein ectodomain in complex with the 22C10 antibody Fab fragment
PDB-8r9x:
Local refinement of the PDCoV spike glycoprotein ectodomain in complex with the 22C10 antibody Fab fragment
PDB-8r9y:
S1B domain of the PDCoV spike glycoprotein in complex with the 67B12 and 42H3 antibody Fab fragments
PDB-8r9z:
S1B domain of the PDCoV spike glycoprotein in complex with the 67B12 and 46E6 antibody Fab fragments
EMDB-18051:
Inward-facing, closed proteoliposome complex I at 3.1 A. Initially purified in DDM.
EMDB-18052:
Inward-facing, open2 proteoliposome complex I at 3.1 A. Initially purified in DDM.
EMDB-18054:
Inward-facing, slack proteoliposome complex I at 3.1 A. Initially purified in DDM.
EMDB-18055:
Outward-facing, closed proteoliposome complex I at 3.1 A. Initially purified in DDM.
EMDB-18057:
Outward-facing, open2 proteoliposome complex I at 3.1 A. Initially purified in DDM.
EMDB-18059:
Outward-facing, slack proteoliposome complex I at 3.1 A. Initially purified in DDM.
EMDB-18066:
Inward-facing, open2 proteoliposome complex I at 2.9 A, after deactivation treatment. Initially purified in LMNG.
EMDB-18067:
Inward-facing, open1 proteoliposome complex I at 3.3 A, after deactivation treatment. Initially purified in LMNG.
EMDB-18068:
Outward-facing, open2 proteoliposome complex I at 2.6 A, after deactivation treatment. Initially purified in LMNG.
EMDB-18069:
Outward-facing, open1 proteoliposome complex I at 2.8 A, after deactivation treatment. Initially purified in LMNG.
EMDB-18138:
Inward-facing, closed proteoliposome complex I at 2.7 A. Initially purified in LMNG.
EMDB-18139:
Inward-facing, open2 proteoliposome complex I at 2.6 A. Initially purified in LMNG.
EMDB-18140:
Inward-facing, open1 proteoliposome complex I at 2.9 A. Initially purified in LMNG.
EMDB-18141:
Outward-facing, closed proteoliposome complex I at 2.5 A. Initially purified in LMNG.
EMDB-18142:
Outward-facing, open2 proteoliposome complex I at 2.6 A. Initially purified in LMNG.
ページ:
wwPDBはEMDBデータモデルのバージョン3へ移行します
